The Windlas Biotech Buyback 2026 last day to buy is not available as of now.

The Windlas Biotech Buyback 2026 is a Tender Offer.

Windlas Biotech Buyback 2026 Schedule

The Windlas Biotech Buyback 2026 is being offered at Rs ₹1000 per share.

Note:

• Small Shareholders are retail shareholders under SEBI regulations.

• General Category includes all other eligible shareholders.

• Entitlement ratio is based on fully paid-up equity shares held on the record date.

The record date for the Windlas Biotech Buyback 2026 is April 24, 2026.

The issue size of Windlas Biotech Buyback 2026 is 4,70,000 equity shares at ₹1000 per share aggregating up to ₹47.00 Crores.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

Return surplus funds to shareholders and enhance overall shareholder returns.
Optimise the Company’s capital structure.

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Windlas Biotech Buyback 2026 offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one’s need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.